Synopsis
Synopsis
0
API Suppliers
0
USDMF
0
CEP/COS
0
JDMF
0
EU WC
0
KDMF
0
NDC API
0
VMF
0
Listed Suppliers
0
API
0
FDF
0
FDF Dossiers
0
FDA Orange Book
0
Europe
0
Canada
0
Australia
0
South Africa
0
Listed Dossiers
DRUG PRODUCT COMPOSITIONS
0
EDQM
0
USP
0
JP
0
Others
0
US Patents
0
US Exclusivities
0
Health Canada Patents
0
Data Compilation #PharmaFlow
0
Stock Recap #PipelineProspector
0
Weekly News Recap #Phispers
0
News #PharmaBuzz
US Medicaid
NA
Annual Reports
NA
Finished Drug Prices
NA
1. 131549-85-4
2. 4-nitroso Sulfamethoxazole
3. Nitrososulfamethoxazole
4. Nitroso Sulphamethoxazole
5. Smx-no
6. N-(5-methyl-3-isoxazolyl)-4-nitrosobenzenesulfonamide
7. N-(5-methyl-1,2-oxazol-3-yl)-4-nitrosobenzenesulfonamide
8. 4-nitroso Sulfamethoxazole, > 90%
9. Kk4e4d7f9y
10. Benzenesulfonamide, N-(5-methyl-3-isoxazolyl)-4-nitroso-
11. Chebi:53017
12. N-(5-methylisoxazol-3-yl)-4-nitrosobenzenesulfonamide
13. Epitope Id:115001
14. Unii-kk4e4d7f9y
15. Chembl3827762
16. Dtxsid60157105
17. Zinc5138878
18. Akos030239892
19. 4-nitroso Sulfamethoxazole, > 90per Cent
20. Ft-0672999
21. 4-nitrososulfamethoxazole, Analytical Standard
22. C90154
23. J-006022
24. 4-nitroso-n-(5-methyl-3-isoxazolyl)benzenesulfonamide
25. Q27123889
26. N-(5-methyl-1,2-oxazol-3-yl)-4-nitrosobenzene-1-sulfonamide
| Molecular Weight | 267.26 g/mol |
|---|---|
| Molecular Formula | C10H9N3O4S |
| XLogP3 | 0.9 |
| Hydrogen Bond Donor Count | 1 |
| Hydrogen Bond Acceptor Count | 7 |
| Rotatable Bond Count | 3 |
| Exact Mass | 267.03137695 g/mol |
| Monoisotopic Mass | 267.03137695 g/mol |
| Topological Polar Surface Area | 110 Ų |
| Heavy Atom Count | 18 |
| Formal Charge | 0 |
| Complexity | 386 |
| Isotope Atom Count | 0 |
| Defined Atom Stereocenter Count | 0 |
| Undefined Atom Stereocenter Count | 0 |
| Defined Bond Stereocenter Count | 0 |
| Undefined Bond Stereocenter Count | 0 |
| Covalently Bonded Unit Count | 1 |
4-Nitrososulfamethoxazole has known human metabolites that include [(2R)-2-[[(4S)-4-amino-4-carboxybutanoyl]amino]-3-(carboxymethylamino)-3-oxopropyl]sulfanyl-[4-[(5-methyl-1,2-oxazol-3-yl)sulfamoyl]phenyl]-oxoazanium.
S73 | METXBIODB | Metabolite Reaction Database from BioTransformer | DOI:10.5281/zenodo.4056560
ABOUT THIS PAGE
A Nitroso Sulphamethoxazole manufacturer is defined as any person or entity involved in the manufacture, preparation, processing, compounding or propagation of Nitroso Sulphamethoxazole, including repackagers and relabelers. The FDA regulates Nitroso Sulphamethoxazole manufacturers to ensure that their products comply with relevant laws and regulations and are safe and effective to use. Nitroso Sulphamethoxazole API Manufacturers are required to adhere to Good Manufacturing Practices (GMP) to ensure that their products are consistently manufactured to meet established quality criteria.
A Nitroso Sulphamethoxazole supplier is an individual or a company that provides Nitroso Sulphamethoxazole active pharmaceutical ingredient (API) or Nitroso Sulphamethoxazole finished formulations upon request. The Nitroso Sulphamethoxazole suppliers may include Nitroso Sulphamethoxazole API manufacturers, exporters, distributors and traders.
Nitroso Sulphamethoxazole Active pharmaceutical ingredient (API) is produced in GMP-certified manufacturing facility.
GMP stands for Good Manufacturing Practices, which is a system used in the pharmaceutical industry to make sure that goods are regularly produced and monitored in accordance with quality standards. The FDA’s current Good Manufacturing Practices requirements are referred to as cGMP or current GMP which indicates that the company follows the most recent GMP specifications. The World Health Organization (WHO) has its own set of GMP guidelines, called the WHO GMP. Different countries can also set their own guidelines for GMP like China (Chinese GMP) or the EU (EU GMP).
PharmaCompass offers a list of Nitroso Sulphamethoxazole GMP manufacturers, exporters & distributors, which can be sorted by USDMF, JDMF, KDMF, CEP (COS), WC, API price, and more, enabling you to easily find the right Nitroso Sulphamethoxazole GMP manufacturer or Nitroso Sulphamethoxazole GMP API supplier for your needs.
A Nitroso Sulphamethoxazole CoA (Certificate of Analysis) is a formal document that attests to Nitroso Sulphamethoxazole's compliance with Nitroso Sulphamethoxazole specifications and serves as a tool for batch-level quality control.
Nitroso Sulphamethoxazole CoA mostly includes findings from lab analyses of a specific batch. For each Nitroso Sulphamethoxazole CoA document that a company creates, the USFDA specifies specific requirements, such as supplier information, material identification, transportation data, evidence of conformity and signature data.
Nitroso Sulphamethoxazole may be tested according to a variety of international standards, such as European Pharmacopoeia (Nitroso Sulphamethoxazole EP), Nitroso Sulphamethoxazole JP (Japanese Pharmacopeia) and the US Pharmacopoeia (Nitroso Sulphamethoxazole USP).
LOOKING FOR A SUPPLIER?
